Singapore markets close in 1 hour 7 minutes

Vicarious Surgical Inc. (RBOT)

NYSE - NYSE Delayed Price. Currency in USD
Add to watchlist
3.2900-0.1200 (-3.52%)
At close: 04:00PM EST
3.3000 +0.01 (+0.30%)
After hours: 07:35PM EST

Vicarious Surgical Inc.

78 Fourth Avenue
Waltham, MA 02451
United States
617 868 1700

IndustryMedical Devices
Full-time employees153

Key executives

NameTitlePayExercisedYear born
Mr. Adam David SachsCo-Founder, CEO, Pres & Director437.46kN/A1992
Mr. Sammy KhalifaCo-founder, CTO & Director365.22kN/A1991
Mr. William J. Kelly CPA, CPACFO & Treasurer421.13kN/A1971
Mr. Barry Stuart Greene F.A.C.S., M.D.Co-founder & Chief Medical OfficerN/AN/AN/A
Mr. John P. MazzolaSr. VP of OperationsN/AN/A1963
Ms. June Marie Morris Esq.Chief Legal Officer, Gen. Counsel & Sec.N/AN/A1950
Ms. Emma PlouffeVP of Bus. Operations & PeopleN/AN/AN/A
Amounts are as of 31 December 2021, and compensation values are for the last fiscal year ending on that date. Pay includes salary, bonuses, etc. Exercised is the value of options exercised during the fiscal year. Currency in USD.


Vicarious Surgical Inc. engages in developing and selling single-incision surgical robot that virtually transports surgeons inside the patient to perform minimally invasive surgery. It offers Vicarious System, a single-incision surgical robot for ventral hernia repair. The company was incorporated in 2014 and is headquartered in Waltham, Massachusetts.

Corporate governance

Vicarious Surgical Inc.’s ISS governance QualityScore as of 1 December 2022 is 10. The pillar scores are Audit: 10; Board: 9; Shareholder rights: 10; Compensation: 6.

Corporate governance scores courtesy of Institutional Shareholder Services (ISS). Scores indicate decile rank relative to index or region. A decile score of 1 indicates lower governance risk, while 10 indicates higher governance risk.